Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Modules, networks and systems medicine for understanding disease and aiding diagnosis

Open access

Abstract

Many common diseases, such as asthma, diabetes or obesity, involve altered interactions between thousands of genes. High-throughput techniques (omics) allow identification of such genes and their products, but functional understanding is a formidable challenge. Network-based analyses of omics data have identified modules of disease-associated genes that have been used to obtain both a systems level and a molecular understanding of disease mechanisms. For example, in allergy a module was used to find a novel candidate gene that was validated by functional and clinical studies. Such analyses play important roles in systems medicine. This is an emerging discipline that aims to gain a translational understanding of the complex mechanisms underlying common diseases. In this review, we will explain and provide examples of how network-based analyses of omics data, in combination with functional and clinical studies, are aiding our understanding of disease, as well as helping to prioritize diagnostic markers or therapeutic candidate genes. Such analyses involve significant problems and limitations, which will be discussed. We also highlight the steps needed for clinical implementation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-014-0082-6

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A single disease phenotype can be caused by multiple mechanisms. As an example, asthma can be triggered by allergens, microbes and other environmental factors, each of which may activate different disease mechanisms, which are depicted as shared (black) and specific (red) networks.
Figure 1 A single disease phenotype can be caused by multiple mechanisms. As an example, asthma can be triggered by allergens, microbes and other environmental factors, each of which may activate different disease mechanisms, which are depicted as shared (black) and specific (red) networks.CC BY · PubMed Central
Figure 2 A disease module. (a) Conceptual model of how disease-associated genes (blue nodes), identified by high-throughput analysis, tend to co-localize in the human protein-protein interaction network (white nodes), forming a module (blue oval). The genes in the module are assumed to be more important for the disease than extramodular genes. (b) An actual disease module from allergic patients, showing extracellular proteins that were putatively co-regulated with IL13. Blue nodes are associated with cytokine activity, purple nodes are associated with hormone activity, and orange nodes are associated with growth factor activity according to Gene Ontology Molecular Function. The diagram in (b) is reproduced, with permission, from Bruhn et al. Science Translational Medicine 2014 [33].
Figure 2 A disease module. (a) Conceptual model of how disease-associated genes (blue nodes), identified by high-throughput analysis, tend to co-localize in the human protein-protein interaction network (white nodes), forming a module (blue oval). The genes in the module are assumed to be more important for the disease than extramodular genes. (b) An actual disease module from allergic patients, showing extracellular proteins that were putatively co-regulated with IL13. Blue nodes are associated with cytokine activity, purple nodes are associated with hormone activity, and orange nodes are associated with growth factor activity according to Gene Ontology Molecular Function. The diagram in (b) is reproduced, with permission, from Bruhn et al. Science Translational Medicine 2014 [33].CC BY · PubMed Central
Figure 3 A module-based approach to identify disease-relevant diagnostic and therapeutic candidate genes in allergy. (a) Twenty-five putative IL13-regulating transcription factors (TFs) were identified by combining data from mRNA microarrays, sequence-based predictions and the literature. (b) IL13-regulating TFs were validated by siRNA-mediated knockdown of the 25 TFs in human total CD4+ T cells polarized toward TH2 using IL13 as a read-out. The target genes of the TFs were identified by combined siRNA knockdown of the positively screened TFs/known IL13-regulating TFs from literature and microarray analyses. This resulted in a module of genes that was co-regulated with IL13 in TH2-polarized cells and significantly overlapped with differentially expressed genes from allergen-challenged T cells from allergic patients. For further validation experiments, the study focused on module genes that encoded secreted proteins and had not been previously associated with allergy. (c) Functional, diagnostic and therapeutic studies involving one of the module genes, S100A4, were performed in patients with seasonal allergic rhinitis, allergic dermatitis and a mouse model of allergy. (d) Model of S100A4-induced disease mechanisms. Allergic inflammation requires the sensitization of the immune system by allergens, resulting in the production of antigen-specific T cells. The interaction of dendritic cells (DC) in the draining lymph node with T cells is a critical step that is dependent on S100A4. B-cell maturation as a result of T cell-B cell crosstalk (for example, the release of TH2 cytokines by T cells) leads to the production of IgE and IgG1 by plasma cells. Cytokines and chemokines released by T cells stimulate the migration of circulating granulocytes (for example, neutrophils and eosinophils) to the inflammatory site (skin). Differentiation of naïve T cells into CD8+ cytotoxic T cells will exacerbate the skin damage. Blue arrows indicate the flow of the allergic responses. Green arrows indicate the promotion of these processes by S100A4. GEM, gene expression microarray.
Figure 3 A module-based approach to identify disease-relevant diagnostic and therapeutic candidate genes in allergy. (a) Twenty-five putative IL13-regulating transcription factors (TFs) were identified by combining data from mRNA microarrays, sequence-based predictions and the literature. (b) IL13-regulating TFs were validated by siRNA-mediated knockdown of the 25 TFs in human total CD4+ T cells polarized toward TH2 using IL13 as a read-out. The target genes of the TFs were identified by combined siRNA knockdown of the positively screened TFs/known IL13-regulating TFs from literature and microarray analyses. This resulted in a module of genes that was co-regulated with IL13 in TH2-polarized cells and significantly overlapped with differentially expressed genes from allergen-challenged T cells from allergic patients. For further validation experiments, the study focused on module genes that encoded secreted proteins and had not been previously associated with allergy. (c) Functional, diagnostic and therapeutic studies involving one of the module genes, S100A4, were performed in patients with seasonal allergic rhinitis, allergic dermatitis and a mouse model of allergy. (d) Model of S100A4-induced disease mechanisms. Allergic inflammation requires the sensitization of the immune system by allergens, resulting in the production of antigen-specific T cells. The interaction of dendritic cells (DC) in the draining lymph node with T cells is a critical step that is dependent on S100A4. B-cell maturation as a result of T cell-B cell crosstalk (for example, the release of TH2 cytokines by T cells) leads to the production of IgE and IgG1 by plasma cells. Cytokines and chemokines released by T cells stimulate the migration of circulating granulocytes (for example, neutrophils and eosinophils) to the inflammatory site (skin). Differentiation of naïve T cells into CD8+ cytotoxic T cells will exacerbate the skin damage. Blue arrows indicate the flow of the allergic responses. Green arrows indicate the promotion of these processes by S100A4. GEM, gene expression microarray.CC BY · PubMed Central
Figure 4 An idealized systems medical approach to personalized treatment. (a) All factors that influence a disease can potentially be described by networks. For example, symptoms and signs that tend to co-occur can be linked and form a module that corresponds to a disease (pink oval). That module may be linked to underlying modular protein changes (blue oval). Similarly, the disease module may be linked to co-occurring environmental factors (green oval). (b) Each of the modules in (a) can be further divided to represent different sublayers, from which (c) predictive markers from the different sublayers can be identified, and used for (d) personalized treatment. MLDM, multilayer disease module; nc-RNA, noncoding RNA; PPI, protein-protein interaction; SNPs, single-nucleotide polymorphisms.
Figure 4 An idealized systems medical approach to personalized treatment. (a) All factors that influence a disease can potentially be described by networks. For example, symptoms and signs that tend to co-occur can be linked and form a module that corresponds to a disease (pink oval). That module may be linked to underlying modular protein changes (blue oval). Similarly, the disease module may be linked to co-occurring environmental factors (green oval). (b) Each of the modules in (a) can be further divided to represent different sublayers, from which (c) predictive markers from the different sublayers can be identified, and used for (d) personalized treatment. MLDM, multilayer disease module; nc-RNA, noncoding RNA; PPI, protein-protein interaction; SNPs, single-nucleotide polymorphisms.CC BY · PubMed Central
Figure 5 Relationship between different disease modules on the protein-protein interaction network. (a) A hypothetical model of three different diseases mapped on the human protein-protein interaction network. The modules are dispersed in the network. (b) Instead, meta-analysis of mRNA microarray and genome-wide association study data show that disease modules partially overlap and form a shared module (grey) [39]. The shared module has important pathogenic, diagnostic and therapeutic implications.
Figure 5 Relationship between different disease modules on the protein-protein interaction network. (a) A hypothetical model of three different diseases mapped on the human protein-protein interaction network. The modules are dispersed in the network. (b) Instead, meta-analysis of mRNA microarray and genome-wide association study data show that disease modules partially overlap and form a shared module (grey) [39]. The shared module has important pathogenic, diagnostic and therapeutic implications.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 1

  1. McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MYC, Kim KY, Tricoli JV, Taylor JM, Shuman DJ, Simon RM, Doroshow JH, Conley BA: Criteria for the use of omics-based predictors in clinical trials. Nature. 2013, 502: 317-320. · DOI · Paper page

Cited by

See all 194

Metadata

Authors
Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., Picotti, P., Pujana, M. Á., Rajewsky, N., Smith, K. G., Sterk, P. J., Villoslada, P., & Benson, M.
Affiliations
  • Linköping University (SE)
  • University of California, San Francisco (US)
  • Imperial College London (GB)
  • Georgetown University Medical Center (US)
  • European Molecular Biology Laboratory (DE)
  • Institute of Genetics and Cancer (GB)
  • University of Zurich (CH)
  • Institut d'Investigació Biomédica de Bellvitge (ES)
  • Max Delbrück Center (DE)
  • University of Cambridge (GB)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Hospital Clínic de Barcelona (ES)
Corresponding author
Benson, Mikael
Venue
Genome Medicine
Published
2014-10-17
Volume
6
Issue
10
Pages
82-82
ISSN
1756-994X (ISSN-L)
OpenAlex
W2156695919
Cited by
194
References
70
Citations by year
2026: 10 · 2025: 6 · 2024: 10 · 2023: 13 · 2022: 11 · 2021: 19 · 2020: 20 · 2019: 20 · 2018: 24 · 2017: 23 · 2016: 20 · 2015: 16 · 2014: 2
FWCI
8.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, cc-by)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, public-domain)
  • National University of Singapore (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • Wellcome Trust (100140)
  • European Commission
  • Linköpings Universitet
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BB/J021032/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
Keywords
systems medicine, gene interaction networks, disease modules, multi-omics integration, network analysis, asthma, allergy, diabetes mellitus, obesity, candidate gene identification, diagnostic biomarkers, drug target prioritization, clinical implementation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modules, networks and systems medicine for understanding disease and aiding diagnosis. https://app.cochat.ai/papers/10.1186/s13073-014-0082-6
The paper
Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., Picotti, P., Pujana, M. Á., Rajewsky, N., Smith, K. G., Sterk, P. J., Villoslada, P., & Benson, M. (2014). Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Medicine. https://doi.org/10.1186/s13073-014-0082-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.